Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.36 |
| ▸ | SMARCA2 | P51531 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1596595 | 0.86 | HSD17B10 (0.44) | HSD17B10ALDH1A1LMNAHPGDSMARCA2 | |
| SCHEMBL5174258 | 0.79 | ALDH1A1 (0.52) | CYP2A6CSNK2A1HSD17B10ALDH1A1SMN1; SMN2 | |
| SCHEMBL7246163 | 0.79 | CYP2A6 (0.46) | CYP2A6CSNK2A1HSD17B10ALDH1A1SMN1; SMN2 | |
| SCHEMBL1596288 | 0.78 | HSD17B10 (0.57) | CYP2A6CSNK2A1HSD17B10ALDH1A1SMN1; SMN2 | |
| SCHEMBL1596886 | 0.78 | ESR2 (0.39) | CYP2A6HSD17B10ALDH1A1SMN1; SMN2CYP1A2 | |
| SCHEMBL30343480 | 0.78 | HSD17B10 (0.57) | CYP2A6CSNK2A1HSD17B10ALDH1A1SMN1; SMN2 | |
| SCHEMBL4687459 | 0.76 | CYP2A6 (0.43) | CYP2A6CSNK2A1HSD17B10ALDH1A1SMN1; SMN2 | |
| SCHEMBL1595637 | 0.75 | CYP3A4 (0.55) | HSD17B10ALDH1A1SMN1; SMN2CYP1A2CYP2C9 | |
| SCHEMBL1596056 | 0.74 | KMT2A (0.42) | CYP2A6HSD17B10ALDH1A1SMN1; SMN2CYP1A2 | |
| SCHEMBL27685446 | 0.71 | CSNK2A1 (0.49) | CYP2A6CSNK2A1HSD17B10ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1780224-B1 | MULTIBRANCHED POLYMERS AND PROCESS FOR PRODUCTION THEREOF | NIPPON SODA CO (JP) | 2015-02-18 | — | — | EP | disclosed |
| US-8710165-B2 | Multibranched polymer and method for producing the same | NIPPON SODA CO., LTD. (JP) | 2014-04-29 | — | — | US | disclosed |
| US-20110152388-A1 | Multibranched polymer and method for producing the same | NIPPON SODA CO., LTD. (JP) | 2011-06-23 | — | — | US | disclosed |
| US-7919570-B2 | narrowly dispersed; controlled molecular weight; ionic conductivity, shape stability; battery adhesive or binder; 1,1,2,2-tetrakis(4-hydroxyphenyl)ethane or pentaerythritol reacted with bromoisobutyroyl bromide for core; living radical polymerization of acrylate or a styrene at halogen atoms as the arms | NIPPON SODA CO., LTD. (JP) | 2011-04-05 | — | — | US | disclosed |
| US-7601784-B2 | 1,1,2,2-tetrakis(4-hydroxyphenyl)ethane is used to molecular alignment, chemical stabilization, heat resist, flexiable and modification of the polyether having hydrogen bond sites; for waste water treatments, energy transducers, conductors | NIPPON SODA CO., LTD. (JP) | 2009-10-13 | — | — | US | disclosed |
| US-20080214685-A1 | Multibrached Polymer and Method for Producing the Same | NIPPON SODA CO., LTD. (JP) | 2008-09-04 | — | — | US | disclosed |
| EP-1792947-A1 | Molecular compound comprising polymer having hydrogen bond as component compound | NIPPON SODA CO., LTD. (JP) | 2007-06-06 | — | — | EP | disclosed |
| EP-1780224-A1 | MULTIBRANCHED POLYMERS AND PROCESS FOR PRODUCTION THEREOF | NIPPON SODA CO., LTD. (JP) | 2007-05-02 | — | — | EP | disclosed |
| US-20050228167-A1 | Molecular compounds containing polymers having hydrogen bond sites as the constituent compounds | NIPPON SODA CO., LTD. (JP) | 2005-10-13 | — | — | US | disclosed |
| US-20020193528-A1 | Molecular compound comprising polymer having hydrogen bond as component compound | NIPPON SODA CO., LTD. (JP) | 2002-12-19 | — | — | US | disclosed |
| EP-1241230-A1 | MOLECULAR COMPOUND COMPRISING POLYMER HAVING HYDROGEN BOND AS COMPONENT COMPOUND | NIPPON SODA CO., LTD. (JP) | 2002-09-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020193528-A1 | Molecular compound comprising polymer having hydrogen bond as component compound | PIEZO1, PARN, PARG | CYP2A6 4784/4885CSNK2A1 1707/4885HSD17B10 3191/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.